-
×
DAPAFON 10
1 × ₹2,399.00
Subtotal: ₹2,399.00
Sitagliptin Phosphate & Metformin Hydrochloride Tablets – JENTIN M 50/500
₹1,799.00
Tablet
Sitagliptin 50mg + Metformin 500mg – 10*15 Pack
Sitagliptin Phosphate & Metformin Hydrochloride Tablets – Modern Diabetes Relief with Consistent Balance and Daily Comfort…
JENTIN M 50/500 – Sitagliptin 50mg + Metformin 500 mg is a synergistic oral antidiabetic formulation designed to treat Type 2 Diabetes Mellitus effectively. It combines two powerful agents:
Sitagliptin is a DPP-4 inhibitor that increases the availability of incretin hormones. It promotes insulin secretion in response to meals and suppresses inappropriate glucagon release, thereby reducing hepatic glucose production.
Metformin, a time-tested biguanide, reduces hepatic glucose output and enhances insulin sensitivity in muscle and fat tissues.
Together, these agents ensure comprehensive and sustained blood sugar control and type 2 diabetes management while minimizing the risk of hypoglycemia and cardiometabolic factors.
Recommended by Specialists:
✅Diabetologists: This is for targeted management of Type 2 Diabetes Mellitus, especially in patients requiring combination therapy to improve insulin sensitivity and augment the incretin pathway.
✅General Physicians –For adults with inadequate diabetes management, offering effective control over fasting and postprandial blood glucose levels.
✅Cardiologists – For diabetic patients with cardiometabolic risk factors.
Key Benefits of Sitagliptin Phosphate & Metformin Hydrochloride Tablets – JENTIN M 50/500
✅Dual-Action Glycaemic Control: Combines two proven mechanisms to regulate blood glucose levels efficiently with a low risk of hypoglycemia.
✅Extended-Release Formulation: The extended-release form of Metformin minimizes the risk of gastrointestinal side effects and ensures steady glucose control throughout the day.
✅Improved Patient Tolerance: This tablet offers a favorable safety profile compared to antidiabetic medications such as sulfonylurea derivatives and insulin-based therapies, enhancing patient compliance.
Indications:
✅Type 2 Diabetes Mellitus
✅Patients with insulin resistance and cardiometabolic risk factors
Related Products
Follow us on
Proin volutpat vitae libero at tincidunt. Maecenas sapien lectus, vehicula vel euismod sed, vulputate
10% off when you sign up
Proin volutpat vitae libero at tincidunt. Maecenas sapien lectus, vehicula vel euismod sed, vulputate
Fawn Incor Private Limited
Fawn Incor Private Limited is one of the fastest-growing and rapidly developing PCD Pharma Franchise Company in India. With proven expertise in the healthcare sector, we cater to the diverse needs of our customers by offering a wide range of general and specialty divisions, including Gynecology, Dermatology, Orthopedics, Neurology, Ophthalmology, Cardiac-Diabetic care, and PPIs.
USEFUL LINKS
Contact us
Panchkula (Admin Office)
Plot No 404, Basement, Industrial Area, Phase I, Panchkula (HR) 134113
Mumbai(Corporate Office)
3rd Floor, Tree House, Raghuvanshi Mills, Lower Parel (West), Mumbai – 400013 India
Netherlands (Overseas)
Fawn Inc. 217, Lichstraat, Eindhoven, Netherlands
+91-9888099264
+91 6280 986 280
+91-7814201203
info@fawnincor.com
Fawnincor@gmail.com
Copyright © Fawn Incor Pvt. Ltd. 2024. All Rights Reserved.
